Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-37,400
Closed -$6.44M 612
2017
Q2
$6.44M Sell
37,400
-94,600
-72% -$15.4M 0.24% 52
2017
Q1
$21.7M Sell
132,000
-78,900
-37% -$13.1M 0.16% 86
2016
Q4
$30.8M Buy
210,900
+18,400
+10% +$2.77M 0.14% 107
2016
Q3
$32.1M Sell
192,500
-70,400
-27% -$11.9M 0.15% 102
2016
Q2
$40M Buy
262,900
+68,900
+36% +$10.7M 0.19% 93
2016
Q1
$29.1M Buy
194,000
+28,300
+17% +$4.2M 0.14% 117
2015
Q4
$26.9M Sell
165,700
-260,800
-61% -$41M 0.13% 113
2015
Q3
$59M Buy
426,500
+186,000
+77% +$29.3M 0.24% 67
2015
Q2
$36.9M Buy
240,500
+9,700
+4% +$1.55M 0.17% 98
2015
Q1
$36.9M Buy
230,800
+67,400
+41% +$10.6M 0.17% 115
2014
Q4
$26M Sell
163,400
-21,300
-12% -$3.32M 0.1% 161
2014
Q3
$25.9M Buy
184,700
+19,500
+12% +$2.55M 0.11% 136
2014
Q2
$19.6M Sell
165,200
-74,700
-31% -$8.65M 0.09% 181
2014
Q1
$29.6M Buy
239,900
+85,300
+55% +$10.3M 0.13% 131
2013
Q4
$17.6M Sell
154,600
-52,300
-25% -$5.95M 0.06% 244
2013
Q3
$23.2M Buy
206,900
+17,800
+9% +$1.93M 0.08% 198
2013
Q2
$18.7M Buy
+189,100
New +$19.6M 0.07% 235

Other funds holding AMGN

Timber Hill's AMGN Position: Q2 2018 in Review

Timber Hill sold out of Amgen (AMGN) in Q2 2018, closing a stake of 7,109 shares — an estimated $1.21M sold.

Timber Hill first reported a position in AMGN in Q3 2013 and held it in 10 quarters. The position peaked at $10.5M in Q3 2013. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Timber Hill reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 7,109 Amgen shares in Q2 2018, an estimated $1.21M.
  • Timber Hill first reported a position in Amgen in Q3 2013 and held it in 10 quarters.
  • Timber Hill's Amgen position peaked at $10.5M in Q3 2013.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.